zk1414376.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2014
Commission File Number 000-30902
COMPUGEN LTD.
(Translation of registrant’s name into English)
| |
|
72 Pinchas Rosen Street
|
|
Tel-Aviv 69512, Israel
|
|
(Address of Principal Executive Offices)
|
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-For Form 40-F:
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Compugen Ltd.
On February 10, 2014, the Board of Directors of Compugen Ltd. (the “Company”) appointed Anat Cohen-Dayag, the Company’s President and Chief Executive Officer, as a member of the Company’s Board of Directors. Dr. Cohen-Dayag was not named, and is not expected to be named, to any committee of the Board of Directors. Dr. Cohen-Dayag will not receive any additional compensation as a director.
The information contained in this Report, including the exhibit hereto, is hereby incorporated by reference into the Company’s Registration Statement on Form F-3, File No. 333-185910.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
COMPUGEN LTD.
|
| |
|
Date: February 11, 2014
|
By:
|
/s/ Tami Fishman Jutkowitz
|
|
| |
|
Tami Fishman Jutkowitz
General Counsel
|
|